Neuralink plans to step up production of its brain implants and move to automated procedures in 2026, Elon Musk posted on X.
Musk’s company has been placing the computer chips inside the brains of paralyzed patients as part of a clinical trial, including at University of Miami Health System in April. The company also raised $650 million and hired a former FDA executive in 2025.
“Neuralink will start high-volume production of brain-computer interface devices and move to a streamlined, almost entirely automated surgical procedure in 2026,” Mr. Musk wrote Dec. 31 on his social media platform.
He added that the device’s threads will now go through the dura, a membrane protecting the brain and spinal cord, without having to remove it, calling that a “big deal.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
